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Abstract
Background Context
Adipokines are secreted by white adipose tissue and have been associated with fracture healing. Our
goal was to report the temporal expression of adipokines during spinal fusion in an established rabbit
model.
Purpose
Our goal was to report the temporal expression of adipokines during spinal fusion in an established
rabbit model.
Study Design
The study design included a laboratory animal model.
Methods
New Zealand white rabbits were assigned to either sham surgery (n=2), unilateral posterior spinal fusion
(n=14), or bilateral posterior spinal fusion (n=14). Rabbits were euthanized 1–6 and 10 weeks out from

surgery. Fusion was evaluated by radiographs, manual palpation, and histology. Reverse transcriptionpolymerase chain reaction on the bone fusion mass catalogued the gene expression of leptin,
adiponectin, resistin, and vascular endothelial growth factor (VEGF) at each time point. Results were
normalized to the internal control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (2^ΔCt),
and control bone sites (2^ΔΔCt). Quantitative data were analyzed by two-factor analysis of variance
(p<.05).
Results
Manual palpation scores, radiograph scores, and histologic findings showed progression of boney fusion
over time (p<.0003). The frequency of fusion by palpation after 4 weeks was 68.75%. Leptin expression
in decortication and bone graft sites peaked at 5 weeks after the fusion procedure (p=.0143),
adiponectin expression was greatest 1 week after surgery (p<.001), VEGF expression peaked at 4 weeks
just after initial increases in leptin expression (p<.001), and resistin decreased precipitously 1 week after
the fusion procedure (p<.001).
Conclusions
Leptin expression is likely associated with the maturation phase of bone fusion. Adiponectin and resistin
may play a role early on during the fusion process. Our results suggest that leptin expression may be
upstream of VEGF expression during spinal fusion, and both appear to play an important role in bone
spinal fusion.
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Introduction
Obesity creates a low-grade inflammatory state that affects the pathophysiology of numerous
diseases.1,2,3 Obesity has been implicated in the delay of bone healing after a fracture, osteoarthritis, and
rheumatoid arthritis.4,5,6,7,8,9,10,11 There is evidence that obesity negatively affects bone physiology.12,13,14
Understanding the biochemical pathways that govern the relationship between obesity and bone
metabolism is vital for understanding the efficacy of orthopedic interventions for bone healing.
Adipokines are a group of cytokines produced by white adipose tissues that play a role in the low-grade
inflammatory state associated with obesity.15,16 Adipokines include leptin, resistin, visfatin, adiponectin,
and others.17 The role of adipokines on the risk of fracture and fracture healing is influenced by the type
of adipokine as well the amount of adipokine present both locally and systematically.18,19,20,21 Leptin has
been implicated in fracture healing in a mouse model.11 Leptin receptors have been found on
osteoblasts, implicating its role in bone mineralization, and there is evidence that leptin is vital during
callous formation for fracture healing.11,22,23 Leptin upregulates vascular endothelial growth factor
(VEGF) in cancer cells, and there is research showing the role of VEGF in early vascularization, which
precedes bone formation.24,25,26,27 These processes and growth factors are necessary for spinal fusion.28
The spinal fusion process involves a balance of chemical signals promoting bone formation that is
needed to span the distances between vertebrae. Based on the role of adipokines in bone formation,
adipokines may be essential for the formation of a fusion mass. Khan et al. have identified leptin's role in

organized callous fracture healing using a leptin knockout mouse model.11 The authors concluded that
leptin was critical to fracture callous formation. Our group hypothesized that leptin and other
adipokines play a pivotal role in a rabbit spine fusion model. We selected a well-established rabbit spine
fusion model and modified the design to provide controls for general anesthesia, as well as the local
effects of surgical approach on soft-tissue injury.29,30 Our specific objectives were to identify the gene
expression profile of adipokines during the spinal fusion process and to determine the temporal and
relative relationship of adipokine expression. We hypothesized that the gene expression of leptin,
adiponectin, VEGF, and resistin would be greater than, and specific to, the generation of bone callus
necessary for spinal fusion.

Materials and methods
All experiments were conducted following approval by our Institutional Animal Care and Use
Committee. Thirty 1-year old New Zealand white rabbits were included. The area around the right and
left transverse processes at L5 and L6 were used as points of evaluation. The rabbits were divided into
three groups. The first group was two control rabbits that were anesthetized and had a sham skin
incision with muscular dissection. These rabbits were the control for the surgical procedures. The
second group consisted of 14 rabbits that received the same surgical approach to both L5 and L6 sites,
but one side received an interpositional fat graft to prevent spinal fusion, and the contralateral site
received transverse process decortication and iliac crest autograft application anticipated to form a
bony fusion (unilateral fusion [UL] rabbits). Group 3 consisted of 14 rabbits, which received bilateral
decortication and iliac crest autograft (bilateral fusion [BL] rabbits). Four rabbits (2 from UL group and 2
from BL group) were euthanized at 1, 2, 3, 4, 5, 6, and 10 weeks after their procedure (Fig. 1). The bone
from the non-decorticated transverse processes within the UL group was used as a control for the bone
fusion surgical procedure, including for autografting and loss of mobility of the spine. The control rabbits
were euthanized at 2 weeks after their sham surgery. Our groups were designed to control for the
influence of general anesthesia, surgical approach, and the effect of UL and motion to the expression
pattern of adipokines during spinal fusion. All surgical procedures were performed together with
surgeons with doctor of medicine and doctor of veterinary medicine degrees.

Fig. 1. Illustration of the experimental design.

Radiographic scores
Immediately after euthanasia, dorsal-ventral and lateral digital radiographs of the lumbar spine were
obtained from four rabbits (two from the BL group and two from the UL group) at the 2-, 4-, 6-, and 10week time points to assess the fusion mass. As in previous studies, the radiographs were graded as
either 1 (unfused), 2 (partially fused), or 3 (completely fused).31 The radiographic scoring was performed
by one researcher to reduce variability.

Manual palpation
The fusion mass at the level of interest was assessed using manual palpation. Motion with flexionextension at the level of interest was compared with motion with flexion-extension at adjacent levels.29
The manual palpation examination was scored using a quantitative system from 0 (no fusion) to 4
(complete fusion), similar to that previously published32,33,34 (1=minimal, 2=mild, 3=moderate reduction

of motion, and 4=marked or no movement at the level of interest compared with the adjacent levels). A
complete fusion was defined as 4 out of 4 on the previously mentioned scale at least 4 weeks out from
surgery.35 Surgeons with a doctor of medicine degree and surgeons with doctor of veterinary medicine
degree performed the palpation examination together, and the documented score was agreed upon by
all researchers.

RNA extraction, cDNA synthesis, and quantitative reverse transcription-polymerase
chain reaction
After manual palpation, a representative portion of the medial fusion mass in both Groups 2 and 3 (UL
and BL) was harvested for RNA extraction and gene analysis. The samples were extracted using a
sterilized rongeur. The fusion specimens were snap-frozen in liquid nitrogen and placed at −80°C.
Additionally, normal transverse process bone specimens were harvested from two levels cephalad to
the level of interest and were maintained as separate specimens. The total RNA was extracted using the
guanidinium thiocyanate-phenol-chloroform extraction method (TRIzol and chloroform, Invitrogen,
Carlsbad, CA, USA) and frozen bone specimens were pulverized in liquid nitrogen. The total RNA was
then isolated using standard procedures.36 Primers were designed and verified using the National Center
for Biotechnology Information's Primer-BLAST (Table). Each primer pair was optimized on a heat
gradient to ensure amplification efficiency of around 95%–100%. All reactions were run in triplicate for
each target gene. The data for the four target genes were presented as mean±standard error of the
mean relative mRNA expression normalized to the internal control gene, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (2^ΔCt). This is a standard technique to analyze the relative expression of a
gene as well as to assist as an internal quality control for the polymerase chain reaction (PCR)
analysis.37,38 The four target gene expressions were standardized to independent biological replicate
sites (n=4 samples) from the control surgery group using the 2^(ΔΔCt) method to elucidate mean fold
changes in gene expression. Relative expression levels were obtained by normalization to GAPDH by the
comparative 2^ΔCt method.39 This was performed for both bone from the fusion mass and bone from
the non-fused transverse processes in the UL group. These results were plotted on the same graph to
illustrate differences in expression attributable to the fusion process. Of note, both 18s ribosomal RNA
(18s rRNA) and beta-actin mRNA were tested as potential housekeeping genes during our experiment.
Neither 18s rRNA nor beta-actin mRNA provided accurate levels of gene expression when several
different primer sequences were tested.
Table. Primer sequences for New Zealand white rabbits
Forward primer (5′–3′)
Reverse primer (5′–3′)
Leptin
GCGGAAAGTCCAGGATGACA
CAGGGATGAAGTCCAAACCGA
Adiponectin
AGAGATGGAACCCCTGGTGA
GCTGAATGCTGAGCGGTAGA
Resistin
CACTGTGTCCGGTGGATGAT
CAGGTTCAGGCTCCTCGTTC
VEGF-A
GGCTGCTGCAATGATGAAAG
GTGCTGTAGGAAGCTCATCTC
GAPDH
AGACACGATGGTGAAGGTCG
TGCCGTGGGTGGAATCATAC
VEGF-A, vascular endothelial growth factor A; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

Histology
The treated levels were dissected from the rabbit spine, placed in 10% buffered formalin, and
subsequently decalcified. Serial sections were stained with Mallory aniline blue (MAB) tissue stain as

well as routine hematoxylin and eosin. Sections were evaluated for evidence of fusion, tissue within the
intertransverse process space, and bony remodeling.

Data and statistical analysis
All quantitative data (reverse transcription-polymerase chain reaction [RT-PCR] results, radiographic
scores, and palpation scores) were analyzed by a repeated two-way analysis of variance to compare
among groups and across time to study the effects of surgical model standardization (ie, UL vs. BL) and
time from surgery. The significance level of 0.05 was used in all statistical comparisons. All statistical
analyses were performed with SPSS software (SPSS Inc., Chicago, IL, USA). Relative quantitation of
leptin, adiponectin, resistin, and VEGF gene expression using real-time quantitative PCR was calculated
by the subtraction of the threshold cycle number of the target gene from the internal control reference
gene, GAPDH, expressed as the power of 2 (2^ΔCt). Additionally, the 2^ΔCt of the target gene was
expressed as a ratio to control rabbit 2^ΔCt (ΔΔCt).39

Results
All rabbits completed the study and all data were collected as per protocol. The average body weight of
rabbits was 3.53 (±0.38) kg.
Manual palpation scores for rabbits in the UL and BL groups significantly increased with time (duration
since surgery) (p<.0001, Fig. 2). Although not statistically significant (p=.11), there was a trend toward
lower palpation scores (more motion) in UL spines. Both radiographic and manual palpation scores
indicated spine fusion at the Week 5–6 time period. Fusion frequency at 4–10 weeks after surgery was
68.75% (11 of the 16 rabbits). This result did not significantly differ by fusion type as 62.5% (5/8) were
fused in the UL group and 75% were fused in the BL group.

Fig. 2. Graph of mean with quartiles marked of rabbit manual palpation scores (Top) across the weeks evaluated.
Rabbits with unilateral and bilateral decortications and bone grafting were combined for graphic purposes
because there was no statistically significant difference in the score for these two groups (0=no fusion and no
reduction in motion, 1=minimal, 2=mild, 3=moderate reduction of motion and limited movement, and 4=marked
reduction of motion or no movement at the level of interest compared with adjacent levels). Of note, at Weeks 1,
2, 6, and 10, all manual palpation scores were the same. Graph of mean and quartiles of radiographic scores
(Bottom) across the weeks evaluated. Scores for only decortication and bone graft sites were included. All other
groups were scored 1 (1=no fusion, 2=partial fusion, and 3=completely fused). At Week 2, all radiographic scores
were 1, and at Week 10, all radiographic scores were 3. Data show a linear increase in score for manual palpation
and radiographic assessments of spine fusion that plateaus sometime between 5 and 6 weeks.

Radiographic scores significantly increased with time, reaching a plateau at 6 weeks (Fig. 2).
Radiographic imaging over the weeks of spine fusion (Fig. 3A–H) showed no signs of radiographic fusion
at 2 weeks, but bone graft could be identified at sites of decortication and bone grafting. (Fig. 3A and B).
Radiographic fusion was seen in nearly all decortication and bone graft sites (83.33%) by Week 6 and in
0% of the interpositional fat graft sites (Fig. 3F) in all UL rabbits out to 10 weeks. Radiographic scores
increased over time, representing radiographic evidence of progressive fusion (p<.0003) in decorticated
and bone graft sites only. At Week 10, all decorticated and bone-grafted sites had a radiographic score
indicating fusion. (Fig. 3G and H).

Fig. 3. Dorsal-ventral radiographs of rabbit lumbar spines with bilateral decortication and bone graft (left column)
and unilateral decortication and bone graft on one side with interpositional fat graft on the contralateral side (right
column). At 2 weeks, bone graft can be seen bilaterally (A) and unilaterally (B) without bony bridging. The
interpositional fat graft obviated fusion between transverse processes (arrow in B). There was no significant
lucency within the bone graft and evidence of further consolidation of the fusion mass between transverse
processes in radiographs at 4 weeks in C and D. (E and F) Radiographs from rabbits at 6 and 10 postoperative
weeks, respectively. There was a significant bony growth with developing cortical and trabecular bones between
transverse processes by Week 10 (G and H).

Histology of the fusion mass
Bone autograft resorption and endochondral ossification was seen at 2 weeks (Fig. 4A). Cartilage had
formed directly adjacent to autograft fragments within the intertransverse process space. The amount
of endochondral ossification and new bone formation was minimal (Fig. 4B). At 4 weeks, greater osteoid
(Fig. 4C) was present within the intertransverse process space, directly adjacent to the autograft. Bone

had grown within the intertransverse process space and was in the process of developing lamellar bone
by Week 4 (Fig. 4C and D).

Fig. 4. (A) Micrograph from the intertransverse process space from a UL-treated rabbit at 2 postoperative weeks
showing a focus of endochondral ossification (white circle) directly adjacent to an unincorporated bone graft
fragment with empty lacunae (white arrow) (H&E, original magnification=79×). (B) Macroscopic sagittal histology
image of the intertransverse process space from a UL-treated rabbit at 2 postoperative weeks showing
unincorporated bone graft fragments within the intertransverse process space at 2 postoperative weeks (H&E,
either a millimeter scale in the field or 4×). (C) Micrograph from the intertransverse process space from a ULtreated rabbit at 4 postoperative weeks showing a trabecular pattern of de novo bone dorsal to the decorticated
transverse process (H&E, original magnification=79×). (D) Macroscopic sagittal histology image of the
intertransverse process space from a BL-treated rabbit at 4 postoperative weeks showing the development of a
bony fusion mass with the incorporation of bone autograft fragments dorsal to and between the decorticated
transverse processes (white arrows) at 4 postoperative weeks (H&E, millimeter scale in the field). UL, unilateral
fusion; H&E, hematoxylin and eosin; BL, bilateral fusion.

The fusion mass continued to mature at 6 and 10 weeks (Fig. 5A–D) as demonstrated by consolidating
bone with the incorporation of the autograft fragments. There was evidence of osteoblasts facilitating
bone growth (Fig. 5A). By 10 weeks, bone growth and maturation resulted in a de novo fusion mass
(Fig. 5C and D). A cement line was found between the autograft and newly formed de novo bone.
Histology confirmed substantial bone growth and maturation of the fusion mass that coincided with loss
of spine mobility as assessed by a manual palpation score. There was a greater amount of de novo bone
formation within the 4- and 6-week groups as compared with the 10-week group. This result may reflect
the normal coupling of bone formation and bone remodeling that results in a smaller final bone callous
volume.40,41

Fig. 5. (A) Micrograph from a BL-treated rabbit at 6 postoperative weeks showing hypertrophied osteoblasts and
several foci of intramembranous ossification. Bone autograft fragments (with empty osteocyte lacunae) are
incorporated into the developing fusion mass within the intertransverse process space at 6 postoperative weeks
(H&E, original magnification=125×). Macroscopic sagittal histology image (B) of the intertransverse process space
from a UL-treated rabbit at 6 postoperative weeks showing substantial bony growth and the development of a
bony fusion mass with the incorporation of bone autograft fragments dorsal to and between the decorticated
transverse processes (white arrows) at 6 postoperative weeks (MAB, millimeter scale in the field). Micrograph (C)
from a BL-treated rabbit at 10 postoperative weeks showing hypertrophied osteoblasts and foci of
intramembranous ossification. Bone autograft fragments (with empty osteocyte lacunae) are incorporated into the
developing fusion mass within the intertransverse process space at 10 postoperative weeks. A cement line is
observed between autograft and newly formed de novo bone (white arrow) (H&E, original magnification=79×). (D)
Macroscopic sagittal histology image of the treated intertransverse process space from a BL-treated rabbit at 10
postoperative weeks showing the development of a bony fusion mass with the incorporation of bone autograft
fragments dorsal to and between the decorticated transverse processes (white arrows) (MAB, millimeter scale in
the field). H&E, hematoxylin and eosin; BL, bilateral fusion.

Quantitative RT-PCR
The results of RT-PCR adipokine gene expression are presented as (2^ΔCt) in Fig. 6A–D. There were no
significant differences in gene expression between bone from two levels cephalad to the level of interest
in the BL and UL groups, bone from the level of interest in control rabbits, and bone from the
contralateral non-fused side at the level of interest in the UL group (p>.05), indicating representation of
a non-fusing bone. We selected the interpositional fat graft procedure as the control comparison to the
decortication and bone graft fusion mass for illustrative purposes for PCR data, but results did not differ
when decortication and bone graft data were compared with sham control or adjacent spine levels.
Expression of adiponectin, resistin, VEGF, and leptin within the decortication and bone graft fusion mass

showed significant (p<.05) time-dependent changes corresponding to different histologic findings,
radiographic results, and manual palpation scores at different time points (Fig. 6A–D). There were no
significant changes in leptin, VEGF, resistin, or adiponectin within the control interpositional fat graft
mass, indicating that these variations in gene expression of these adipokines was bone fusion specific.
Leptin increased during the 3- to 6-week time frame, spiking at 5 weeks. This finding corresponded to
increased bone formation, incorporation of bone graft, and development of woven bone between
transverse processes (Fig. 4, Fig. 5). The timing of this increase in leptin corresponded to the
incorporation of bone graft with the remodeling of the fusion mass.
Adiponectin expression was greatest 1 week after surgery only in the sites receiving decortication and
bone graft (Fig. 6B). This corresponded to the initial reactive phase to bone graft and the decortication
procedure. Adiponectin expression decreased by 2 weeks and no longer differed from the control
interpositional fat graft site for the rest of the study.
Resistin expression decreased during the middle, reparative phase of the spinal fusion. There was a
mixture of woven and lamellar bones developing between transverse processes during these time
periods (Fig. 4, Fig. 5). At 6–10 weeks, resistin returned to Week 1 levels as the fusion mass matured.
Vascular endothelial growth factor expression had two peaks of expression at Weeks 4 and 10, which
were significantly greater than the control sites (p<.05). These time points corresponded to
histopathology findings that had bone development as the dominant tissue activity (Fig. 5A and B).
Normalization of adipokine expression to the control rabbit's bone at Week 2 (ΔΔCt) demonstrated a
similar pattern to the changes in gene expression across time for leptin, adiponectin, vascular
endothelial growth factor A, and resistin (Fig. 7). Specifically, 1.0 was equivalent to baseline expression
from control rabbits. As in the ΔCt data (Fig. 6), leptin downregulated over the first 2 weeks and
increased during the bone formation phase between Weeks 3–5. The increase and the decrease in VEGF
expression occurred just after the increase in leptin and after the decrease in leptin, respectively.

Fig. 6. Illustrations of mean±standard error of the mean gene expression differences in the threshold cycle (2^ΔCt)
number between the target gene and the internal control reference gene, GAPDH. Means without a common
superscript letter differ (p<.05), as analyzed by one-way analysis of variance of leptin (A), adiponectin (B), resistin
(C), and VEGF (D). Leptin starts to increase at Week 3, significantly spiking at Week 5. The increase in leptin occurs
just before a significant spike in VEGF expression at Week 4. Both resistin and adiponectin spike in expression
during the initial stage of healing at Week 1. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; VEGF, vascular
endothelial growth factor.

Fig. 7. Mean fold change in leptin, adiponectin, resistin, and VEGF-A gene expression standardized to the control
sham surgery group using the 2(−ΔΔCt) method. Note the uptick in leptin expression that is upstream from an
increase in vascular endothelial growth factor. There is a substantial increase in leptin expression by Week 5. Also,
the same trends in Fig. 6 are reflected in the patterns of mean fold expression shown in this figure. This includes
the increase in adiponectin and resistin in the initial week of healing. VEGF-A, vascular endothelial growth factor A.

Discussion
Our study showed significant patterns of adipokine gene expression unique to each adipokine, which
varied during the spinal fusion process. Leptin expression spiked within the fusion mass during the bony
remodeling phase at 3–6 weeks. Adiponectin expression contrastingly is relatively greater initially during
the reactive phase and decreases dramatically shortly thereafter. When comparing expression profiles,
there was evidence that the expression of leptin is upstream to that of VEGF, given that the increases in
leptin occurred just before the increases in VEGF expression. These findings are consistent with previous
research on the role of leptin within bony healing.11,42,43,44,45 Our data support this importance of leptin
for bony healing phases of spinal fusion. The results of our experiment were consistent with our initial
hypothesis in that leptin and VEGF expression increased during the remodeling phase of callus formation
for the spinal fusion process. Results related to the differing expression of adiponectin and resistin,
however, were unexpected given that these adipokines increased initially during the inflammatory
phase of healing and only rose again during the final late or remodeling phase for the fusion mass.
Our results indicate that adipokine expression varies significantly during the spinal fusion process. As
mentioned previously, there is an established link between adipokines and the low-grade inflammatory
state of obesity.15,16 Therefore, the change in normal homeostasis of adipokine expression at the local
and systemic level for obese patients might contribute to the poor clinical outcomes for the obese
population.46,47,48 Further research is needed to determine how adipokine expression at the local or
systemic level changes for obese patients undergoing spinal fusion surgery and how these changes
might affect clinical outcomes.
The coordinated expression profile of leptin and VEGF suggested that these factors are connected. The
high expression of VEGF within the bony remodeling phase of healing as well as the final remodeling

phase of healing (at 10 weeks) has been demonstrated in previous studies.49,50 Leptin has been shown to
increase the expression of the VEGF and the VEGF receptor on mouse mammary cancer cells.27 Although
we did find in vitro reports on the impact of leptin on the VEGF or the VEGF receptor within a fusion
mass, our data suggested that this same upstream position of leptin might exist in vivo for bony healing.
We found that VEGF expression was more transient than leptin, as it decreased after the initial spike in
leptin. Leptin, therefore, may trigger angiogenesis in spinal fusion, as during fracture healing.51
Adiponectin expression during the initial reactive response to decortication and bone grafting decreased
after Week 1, with a significantly greater decrease than in the interpositional fat graft sites, and our data
suggested this drop might be linked to initial bone healing. Previous research has shown contrasting
results in terms of the effect of adiponectin on bone remodeling.52,53,54,55,56 There was a complex role of
adiponectin in bone healing, and the impact of adiponectin may depend on the timing and the amount
of the adiponectin activity.52,55 Our results suggested that local expression of adiponectin might precede
initial bone reaction during the inflammatory phase of spinal fusion and might be downregulated during
the growth of a spinal fusion mass.
Our study has several limitations. We were forced to use GAPDH as a housekeeping gene as a control
because of our inability to find the correct primer sequence for New Zealand white rabbits for either 18s
rRNA or beta-actin mRNA. The authors acknowledge that there may be a variation in the expression of
GAPDH that could have influenced our results as has been mentioned in previous literature.57,58 We used
the manual palpation examination to assess spinal fusion. Although previous research has demonstrated
the validity of this examination, we acknowledge the subjective nature of this outcome.29,35 In addition
to this assessment, we provided radiographic and histologic assessments of bone remodeling.
Our study goal was to measure the variations and patterns of adipokine expression with bone fusion of
the spine. To assist with this goal, we normalized our data by several methods, and our results showed
similar findings with each of the control comparisons. One comparison for analysis was bone from sham
control rabbits at 2 weeks to UL and BL groups, serving to control for general anesthesia and skin
incision with muscle dissection. Another comparison for analysis was the lumbar sites cephalad and
caudal to L5 and L6 to control for time effects in healthy bone on these same rabbits. The last
comparison for analysis was the interpositional fat graft site at the L5–L6 lumbar space, which provided
comparative information for the effect of soft-tissue injury, tissue grafting, and, potentially, the
retention of limited motion at a surgical site on the adipokine gene expression profile. Given that
changes in leptin, adiponectin, resistin, and VEGF were only seen in the decortication and bone fusion
masses, it followed that these fluctuations in gene expression were likely associated with the bone
fusion process. Future research will be required to examine adipokine expression during the human
spinal fusion process and whether strategic influence through adipokine pathways could be effective in
accelerating this process. There are still many unanswered questions about the precise interplay of
adipokines and bone healing in general and in spinal fusion in particular. We hope our results encourage
research into this topic.
In summary, our study reported the temporal changes in expression of adipokines during spinal fusion.
Leptin is likely associated with the maturation phase of bone fusion at 3–6 weeks and may play a role in
promoting this process as in fracture healing. Adiponectin is associated with the bone reactive and
inflammatory phase of bony fusion and may play a role early on in the fusion process. Vascular
endothelial growth factor expression was temporally associated with leptin expression. This evidence

supported the hypothesis that leptin expression may be upstream of VEGF expression during spinal
fusion. Future research would be required to understand the cascade and interdependence of adipokine
expression within the spinal fusion process in humans. Furthermore, these results underscore the varied
physiological roles that white adipose tissue plays in bone metabolism through adipokines.
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